T1	Participants 112 127	moderate asthma
T2	Participants 428 507	patients with moderate asthma previously treated with an inhaled corticosteroid
T3	Participants 611 821	342 adolescent and adult patients with moderate asthma [forced expiratory volume in 1 second (FEV1) between 50% and 80% of predicted] treated previously by beclomethasone dipropionate or triamcinolone acetonide
T4	Participants 287 293	asthma
T5	Participants 1997 2026	patients with moderate asthma
